Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Shared Decision Making in Hemophilia Patient CareRelease Date:Quality Improvement Rare Disease China Optimizing HRRm Testing and Workflow Integration in mCSPCRelease Date:Quality Improvement, Research Oncology Canada Driving Timely Biomarker Testing to Optimize Treatment Decisions for Colorectal Cancer Patients Across CanadaRelease Date:Partner: Colorectal Cancer Canada (CCC)Quality Improvement, Research Oncology Canada Optimizing Disease Management to Improve Alopecia Areata Quality of CareRelease Date:Quality Improvement Inflammation & Immunology China Providing Appropriate Medical Care for IBD PatientsRelease Date:Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)Quality Improvement Inflammation & Immunology Japan Fostering Educational Initiatives for ALK+ Metastatic Non-Small Cell Lung Cancer(mNSCLC) Tyrosine Kinase Inhibitors(TKI) TherapyRelease Date:Education Oncology Canada 2026 Headache Medicine Fellowship - USRelease Date:Fellowship Internal Medicine USA Advances in Migraine ManagementRelease Date:Education Internal Medicine USA Real-World Evidence of SUL-DUR on Special Populations with CRAB InfectionRelease Date:Research Inflammation & Immunology China Optimizing Atopic Dermatitis Quality of Care and Best Practice at Local LevelRelease Date:Quality Improvement Inflammation & Immunology China Addressing HCP Knowledge Gaps in Baseline Assessments for Adults with Ulcerative Colitis Starting S1P Receptor Modulator TherapyRelease Date:Education Inflammation & Immunology USA Use of AI to Improve Speed/Precision of Treatment Selection & Clinical Management for Patients w/ Invasive Mold InfectionsRelease Date:Education Hospital Australia, China, France, Germany, Italy, Korea, Spain, Taiwan, United Kingdom Quality improvement strategies to enhance quality of life in ALK-positive lung cancer patientsRelease Date:Quality Improvement Oncology Spain Maintenance Therapy in HER2+ Metastatic Breast Cancer (MBC)Release Date:Education Oncology USA Efforts to Improve Quality of Migraine CareRelease Date:Partner: The Japanese Headache SocietyQuality Improvement Internal Medicine Japan Enhancing HCP Education in Adult Vaccination against Respiratory InfectionsRelease Date:Education Vaccines Austria, Belgium, Greece, Ireland, Luxembourg, Portugal, Switzerland Migraine and Women’s HealthQuality Improvement, Research Internal Medicine USA Real World Evidence on clinical outcomes with Aztreonam-Avibactam (ATM-AVI)Release Date:Research Inflammation & Immunology All Improving Health Outcomes in Patients with ATTR-CM Through the Development of a Shared Decision-Making Tool (Decision Aid)Release Date:Research Rare Disease USA Capacity Building for Clinical Trials in Sickle Cell Disease (SCD) - Education for Healthcare ProfessionalsRelease Date:Education Rare Disease USA Prostate Cancer: Best Practices for Combining Targeted Therapies in mPCRelease Date:Education Oncology USA Transthyretin Cardiac Amyloidosis FellowshipRelease Date:Research Rare Disease USA Optimizing Adult Vaccination Ecosystem in IndiaRelease Date:Quality Improvement Vaccines India Evidence Based Safety Contextualization of JAK inhibitors in the Treatment of Moderate to Severe Atopic DermatitisRelease Date:Education Inflammation & Immunology China, France, Germany, Italy, Japan, Korea, Spain, USA Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology Spain Optimizing Clinical Care Delivery for Patients with Multiple Myeloma Receiving Bispecific AntibodiesRelease Date:Quality Improvement Oncology All Enhancing HCP Education in Maternal VaccinationRelease Date:Education Vaccines Saudi Arabia Diagnosis and Treatment of Cancer CachexiaRelease Date:Education Oncology All Evidence-Based Education on the Potential Impact of a Generic JAK Inhibitor on the Management of Rheumatologic DiseasesRelease Date:Education Inflammation & Immunology USA B-cell Maturation Antigen (BCMA) Bi-Specific Antibodies (BsAbs) in Relapsed/Refractory Multiple Myeloma (RRMM)Release Date:Education Oncology USA Education on Mechanism of Action of JAK3 and TEC Family Kinase Role in Alopecia AreataRelease Date:Education Inflammation & Immunology USA 2026 Hemophilia Fellowship – United StatesRelease Date:Fellowship Rare Disease All Pediatric Pneumococcal Disease and Serotype Distribution: Surveillance Studies in Saudi ArabiaRelease Date:Research Vaccines Saudi Arabia Optimising Ulcerative Colitis Care: Bridging Knowledge Gaps, Integrating Biomarker-Based Strategies, and Advancing EquityRelease Date:Education Inflammation & Immunology Australia Surveillance of Pneumococcal Disease Serotype Distribution in Pediatric and Adult Pneumococcal Disease in TürkiyeRelease Date:Research Vaccines Turkey Surveillance of Pneumococcal Disease Serotype Distribution in Pediatric and Adult Pneumococcal Disease in TürkiyeRelease Date:Research Vaccines Turkey Title Grant Type Focus Area Country Application Due Date An Accord for a Healthier World: Digital Health Tools to Improve Multidisciplinary Patient CareRelease Date:Quality Improvement Support for the Professions Senegal PARP-inhibitor Combination Treatments in Prostate CancerRelease Date:Education Oncology China Improving cancer care in patients with metastatic breast cancerRelease Date:Quality Improvement Oncology Kazakhstan An Accord for a Healthier World: Preceptorships for Rheumatology (African French Speaking Countries Geographic Scope)Release Date:Education Inflammation & Immunology All Improving Health Equity in IBD through Disparities ResearchRelease Date:Research Inflammation & Immunology All Emerging Science in the Management of Acute Myeloid LeukemiaRelease Date:Education Oncology All Addressing Systemic Drivers of Racial Health InequitiesRelease Date:Quality Improvement Health Equity USA Diversity in Postmarketing Drug Safety SurveillanceRelease Date:Research Patient Safety USA Addressing Barriers to Care: Destigmatizing Breast Cancer through Patient EducationRelease Date:Education Oncology Ghana, Rwanda Increasing Awareness and Understanding of Duchenne Muscular Dystrophy in Latin America, Africa, Middle East and Asia-PacificRelease Date:Education Rare Disease All Improving Education Disparities of Young Gatroenterologists to Deliver Appropriate Medical Care to IBD PatientsRelease Date:Education Inflammation & Immunology Argentina, Brazil, India, Malaysia, Mexico, Russia, Saudi Arabia, Singapore, Turkey, United Arab Emirates 2023 Inflammatory Bowel Disease (IBD) Fellowship – IndiaRelease Date:Fellowship Inflammation & Immunology India Multidisciplinary Team Education in Duchenne Muscular Dystrophy (see RFP for specific geographic scope)Release Date:Education Rare Disease All 2023/2024 Global NASH ASPIRERelease Date:Research Internal Medicine All Improving Metastatic Breast Cancer (mBC) Quality of Care and Equity via Meaningful Capacity Building in South East AsiaRelease Date:Partner: Conquer Cancer®, the ASCO FoundationQuality Improvement Oncology Hong Kong, Indonesia, Malaysia, Myanmar, Papua New Guinea, Philippines, Singapore, Solomon Islands, Taiwan, Thailand, Vietnam Alopecia Areata Education for Pediatric Dermatologists, Dermatologists, and Advanced Practice ProvidersRelease Date:Education Inflammation & Immunology USA Implementation of Revised USP <797> Pharmaceutical Compounding-Sterile Preparations: Challenges and OpportunitiesRelease Date:Education Hospital USA Improving Care for Patients with Multiple MyelomaRelease Date:Education Oncology USA HRRm Testing in Metastatic Prostate CancerRelease Date:Education Oncology All Advancing Oncology Education for Healthcare ProfessionalsRelease Date:Education Oncology Benin, Burkina Faso, Burundi, Cameroon, Central African Republic, Chad, Comoros, Congo, Congo, The Democratic Republic, Cote D'ivoire, Djibouti, Gabon, Guinea, Madagascar, Mali, Niger, Rwanda, Senegal, Seychelles, Togo Providing Appropriate Medical Care for IBD PatientsRelease Date:Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)Quality Improvement Inflammation & Immunology Japan Real World Evidence of Abrocitinib in Patients with Moderate-to-Severe Atopic DermatitisRelease Date:Research Inflammation & Immunology All Addressing Gaps in Care for Patients with Multiple Myeloma (Europe)Release Date:Education Oncology All Improving Breast Cancer (BC) Quality of Care via Meaningful Capacity Building in Sub-Saharan AfricaRelease Date:Partner: Conquer Cancer®, the ASCO FoundationReview Process: Expert Review PanelQuality Improvement Oncology Congo, The Democratic Republic, Ethiopia, Ghana, Malawi, Mali, Mozambique, Rwanda, Senegal, Tanzania, United Republic of, Uganda, Zambia, Zimbabwe Improving the Care of Persons Living with Metastatic Breast CancerRelease Date:Partner: Rethink Breast CancerQuality Improvement Oncology Canada Addressing knowledge and practice gaps in changing paradigms of dermatological inflammatory conditionsRelease Date:Education Inflammation & Immunology Canada Improving Advanced Prostate Cancer Management in Latin AmericaEducation Oncology Argentina, Brazil, Chile, Colombia, Mexico Investigating the Value of Using Patient-Reported Outcomes in Oncology Patient CareResearch Oncology USA Addressing Knowledge Gaps in Ulcerative Colitis (UC) CareRelease Date:Education Inflammation & Immunology USA 2024 Inflammatory Bowel Disease (IBD) Fellowship – United StatesRelease Date:Fellowship Inflammation & Immunology USA Closing the HRRm Testing Gap in Prostate Cancer PatientsRelease Date:Quality Improvement Oncology Canada Improving the care and outcomes of residents of Canada living with metastatic NSCLCRelease Date:Partner: Lung Health Foundation, Lung Cancer Canada, Quebec Lung AssociationQuality Improvement Oncology Canada Improving the Equity and Quality of Cancer Care in ColombiaRelease Date:Partner: The Colombian Association of Oncology and Hematology (ACHO)Quality Improvement Oncology Colombia Enhancing Molecular Testing for Metastatic Colorectal Cancer PatientsRelease Date:Partner: Colorectal Cancer Canada (CCC)Quality Improvement Oncology Canada Diagnosis and Diagnostic Tests for Metallo-β-Lactamase (MBL) Producing Bacterial InfectionsRelease Date:Education Hospital All IBD QORUS HEALTH EQUITY REQUEST FOR APPLICATIONS (RFA)Release Date:Partner: Crohn's & Colitis FoundationQuality Improvement Inflammation & Immunology USA 2024 Raising Awareness and Promoting Timely Diagnosis of TTR AmyloidosisRelease Date:Partner: Global Bridges at Mayo ClinicQuality Improvement Rare Disease All Junior Investigator Global ATTR Cardiac Amyloidosis ResearchRelease Date:Research Rare Disease Australia, Canada, France, Germany, Italy, Japan, Korea, Spain Reducing Barriers to Optimal Clinical Care in Breast CancerRelease Date:Quality Improvement Oncology Spain Quality Improvement Grants to Improve Identification and Management of Patients with ATTR AmyloidosisRelease Date:Quality Improvement Rare Disease Spain Advances in Migraine ManagementRelease Date:Education Internal Medicine USA 2024 IM US Headache Medicine FellowshipRelease Date:Fellowship Internal Medicine USA RSV Infection and RSV Maternal Immunization in Area of Obstetrics and GynecologyRelease Date:Education Vaccines Japan Transthyretin Cardiac Amyloidosis FellowshipRelease Date:Fellowship Rare Disease USA Increasing Awareness and Understanding of Amyloid Transthyretin Cardiomyopathy (ATTR-CM)Release Date:Education Rare Disease USA Advancing The Use of Oral Anticoagulants in Atrial Fibrillation and Venous ThromboembolismEducation Internal Medicine All Bolstering Clinical Research Capacity to Address China Health Equity DisparitiesRelease Date:Education Health Equity China Quality Improvement Grants to Support Development of Cardiac Amyloid CentersRelease Date:Quality Improvement Rare Disease USA